Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental

by ATHANASIADIS, ATHANASIOS , CHRISTOPOULOU, ATHINA , VARTHALITIS, IOANNIS , KALOFONOS, CHARALAMBOS , PAPATSIMPAS, GEORGIOS , BOUKOVINAS, IOANNIS , ARDAVANIS, ALEXANDROS , PAPANDREOU, CHRISTOS , BOURNAKIS, EVANGELOS , ZIRAS, NIKOLAOS , SOUGGLERI, MARIA , BOKAS, ALEXANDROS , MAKRANTONAKIS, PARIS , PENTHEROUDAKIS, GEORGIOS , STERGIOU, HELEN , ANDREADIS, CHARALAMBOS , PAPAKOTOULAS, PAVLOS , SAMANTAS, EPAMEINONDAS , KOUMAKIS, GEORGIOS , SAMELIS, GEORGIOS , ARAVANTINOS, GERASIMOS , PAPAKOSTAS, PAVLOS , TSOUKALAS, NIKOLAOS , TIMOTHEADOU, ELENI , TRIPODAKI, SOFIA , GRIVAS, ANASTASIOS

in Anticoagulants / Bevacizumab / Bleeding / Body mass index / Body size / Cancer / Cancer therapies / Chemotherapy / Coagulation / Female / Gender / Health risks / Heart failure / Hemorrhage - etiology / Heparin / Humans / Low molecular weights / Male / Medical history / Metastasis / Middle Aged / Molecular weight / Mortality / Neoplasm Recurrence, Local - pathology / Neoplasms - complications / Observational studies / Oncology / Pancreatic cancer / Patients / Renal insufficiency / Risk Factors / Thromboembolism / Thrombosis / Thrombosis - etiology / Thrombosis - therapy / Tomography / Variance analysis

2020

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental

2020

Confirm

Do you wish to request the book?

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental

2020

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental

ATHANASIADIS, ATHANASIOS,

CHRISTOPOULOU, ATHINA,

VARTHALITIS, IOANNIS,

KALOFONOS, CHARALAMBOS,

PAPATSIMPAS, GEORGIOS,

BOUKOVINAS, IOANNIS,

ARDAVANIS, ALEXANDROS,

PAPANDREOU, CHRISTOS,

BOURNAKIS, EVANGELOS,

ZIRAS, NIKOLAOS,

SOUGGLERI, MARIA,

BOKAS, ALEXANDROS,

MAKRANTONAKIS, PARIS,

PENTHEROUDAKIS, GEORGIOS,

STERGIOU, HELEN,

ANDREADIS, CHARALAMBOS,

PAPAKOTOULAS, PAVLOS,

SAMANTAS, EPAMEINONDAS,

KOUMAKIS, GEORGIOS,

SAMELIS, GEORGIOS,

ARAVANTINOS, GERASIMOS,

PAPAKOSTAS, PAVLOS,

TSOUKALAS, NIKOLAOS,

TIMOTHEADOU, ELENI,

TRIPODAKI, SOFIA,

GRIVAS, ANASTASIOS

2020

Overview

Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according to guidelines. A multicenter prospective observational study was carried out to record anti-thrombotic treatment practice, assess thrombosis recurrence and bleeding, and identify potential risk factors. Adult patients from 18 Oncology Departments throughout Greece were followed-up for 12 months. A total of 120 patients with CAT receiving anticoagulant treatment were enrolled (35% incidental); 85% were treated for more than 6 months, 95.8% were treated with tinzaparin and smaller percentages with other agents. Thrombosis recurred in three patients and there was minor bleeding in four patients. Bleeding was associated with high body mass index (>35 kg/m ), trauma history, renal insufficiency and bevacizumab use. Incidental thrombosis contributes significantly to CAT burden. Long-term use of LMWH seems to be effective and safe. Several risk factors associated with bleeding should be considered during anti-coagulation therapy planning.

Share this book

Add to My Shelf

Publisher

International Institute of Anticancer Research

Subject

/ Cancer